Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
We utilize advanced business intelligence and in-depth analytics through AI-augmented research methodologies, incorporating systems thinking, predictive modeling, logic, and data-driven investigation. By bridging intuition, insight, and evidentiary reasoning, we create strategic output that delivers clarity, foresight, and measurable results.

ARIP competes across existing categories but is not identical to any one category. Decision-intelligence platforms automate and optimize decisions, while AI-augmented research methodologies enhance the depth of insights. AI-governance platforms govern models, and research platforms retrieve and summarize information for effective predictive modeling. Workflow tools track tasks efficiently. ARIP governs the full reasoning lifecycle behind complex decisions: hypothesis formation, claim testing, evidence scoring, contradiction review, decision capture, and learning reuse, ultimately driving strategic output.
CBL-iO3 Research Series ARTICLE 1 (18-AUG-25) (pdf)
DownloadCBL-iO3 Research Series ARTICLE 2 (revised 06-SEPT-25) (pdf)
DownloadCBL-iO3 Research Series ARTICLE 3 (28-AUG-25) (pdf)
DownloadCBL-iO3 Research Series ARTICLE 4 (11-SEPT-25) (pdf)
DownloadCBL-iO3 Research Series ARTICLE 5 (11-SEPT-25) (pdf)
DownloadCBL-IO3 Research Series ARTICLE 6 (22-SEPT-25) (pdf)
DownloadCBL-iO3 Research Series ARTICLE 6a (24-SEPT-25) (pdf)
DownloadCBL-iO3 Research Series ARTICLE 7 (28-SEPT-25) (pdf)
DownloadCBL-iO3 Research Series ARTICLE 8 (18-OCT-25) (pdf)
DownloadCBL-iO3 Research Series ARTICLE 9 (27-OCT-25) (pdf)
DownloadCBL-iO3 Research Series ARTICLE 10 (2-NOV-25) (pdf)
DownloadCBL-iO3 Article 11 FINAL (11-NOV-25) (pdf)
DownloadARTICLE 12 Supplemental Update (27-NOV-25) (pdf)
DownloadArticle 12 FINAL (26-NOV-25) (pdf)
DownloadArticle 13 - From Platform to White Knight (18-DEC-25) (pdf)
DownloadARTICLE 1 - Theory of Nothing v1.4 (9-NOV-25) (pdf)
DownloadARTICLE 2 - The Living Circuit v1.5 (15-NOV-25) (pdf)
DownloadARTICLE 3 - The Cosmic Trinity v1.6 (19-NOV-25) (pdf)
DownloadARTICLE 4 - The Universal Equilibriumv1.5 (19-NOV-25) (pdf)
DownloadARTICLE 5 - The Cosmological Information Model v1.2 (21-NOV-25) (pdf)
DownloadARTICLE 6 v1.1 (23-NOV-25) (pdf)
DownloadARTICLE 7 V1.0 (23-NOV-25) (pdf)
DownloadARTICLE 8 v1.1 (24-NOV-25) (pdf)
DownloadARTICLE 9 v1.0 (24-NOV-25) (pdf)
DownloadARTICLE 10 v1 (24-NOV-25) (pdf)
DownloadARTICLE 11 V2.2 (29-NOV-25) (pdf)
DownloadMark Pimentel, MD, is the head of the Pimentel Laboratory and executive director of the Medically Associated Science and Technology (MAST) Program at Cedars-Sinai. This program focuses on the development of drugs, diagnostic tests, and devices related to conditions of the microbiome, utilizing AI-augmented research methodologies and predictive modeling to enhance strategic output. In this Q&A session, Dr. Pimentel discusses his path from growing up in Thunder Bay, Ontario, Canada to leading one of the world's most renowned medical research institutes.
These reports have been prepared for informational and educational purposes only. They represent independent research and speculative analysis by the author, utilizing AI-augmented research methodologies based solely on publicly available sources such as SEC filings, financial statements, trading data, press releases, and industry research.
These reports:
- Do not contain or rely on insider information.
- Do not constitute investment, financial, legal, or professional advice.
- Do not guarantee the occurrence of any event or transaction discussed.
All forward-looking statements, including references to potential mergers, acquisitions, valuations, or strategic outcomes, should be interpreted strictly as hypotheses, utilizing predictive modeling — not predictions or commitments. Readers should conduct their own due diligence and consult qualified advisors before making investment or strategic output decisions.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.